| タイトル |
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
|
| 著者 |
Mitsui Yozo
Hirata Hiroshi
Arichi Naoko
Chang Inik
Fukuhara Shinichiro
Yamamura Soichiro
Shahryari Varahram
Deng Guoren
Saini Sharanjot
Majid Shahana
Dahiya Rajvir
Tanaka Yuichiro
|
| 収録物名 |
ONCOTARGET
|
| 巻 | 6 |
| 号 | 11 |
| 開始ページ | 9577 |
| 終了ページ | 9591 |
| 収録物識別子 |
EISSN 1949-2553
|
| 主題 |
bone morphogenetic protein 2; renal cell carcinoma; DNA methylation; molecular marker
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
IMPACT JOURNALS LLC
|
| 発行日 | 2015-04-20 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[DOI]
10.18632/oncotarget.3445
[PMID]
25797254
|
| 備考 | Address all correspondence and requests for Yozo Mitsui, MD, PhD, Departments of Urology, Shimane University Faculty of Medicine, 89-1 Enya-cho, 693-8501 Izumo, Japan. E-mail: mitsui@med.shimane-u.ac.jp. We thank Dr. Roger Erickson for his support and assistance with the preparation of the manuscript. This research study was supported by the National Center for Research Resources of the NIH through Grant Number RO1CA130860 and VA Merit Review and VA Program Project. |
